Design, synthesis and biological evaluation of lazabemide derivatives as inhibitors of monoamine oxidase
作者:Shiyang Zhou、Guangying Chen、Gangliang Huang
DOI:10.1016/j.bmc.2018.08.024
日期:2018.9
In the studied a series novel of lazabemide derivatives were designed, synthesized and evaluated as inhibitors of monoamine oxidase (MAO-A or MAO-B). These compounds used lazabemide as the lead compound, and the chemistry structures were modified by used the bioisostere and modification of compound with alkyl principle. The two types of inhibitors (inhibition of MAO-A and inhibition of MAO-B) were
在研究中,设计,合成和评估了一系列新的lazabemide衍生物作为单胺氧化酶(MAO-A或MAO-B)的抑制剂。这些化合物以拉沙贝米为先导化合物,并通过对烷基进行化合物的生物等排和修饰,对化学结构进行了修饰。通过对MAO的抑制活性来筛选两种抑制剂(对MAO-A的抑制和对MAO-B的抑制)。体外实验表明,化合物3a,3d和3f具有抑制MAO-A生物学活性的强度,而化合物3i和3m具有强度抑制MAO-B的生物学活性。从体外抑制活性实验的数据可以看出,化合物3d为IC 50 = 3.12±0.05μmol/ mL的MAO-A,化合物3m为IC 50 = 5.04±0.06μmol/ mL。通过检测血浆和脑组织中5-HT,NE,DA的含量以及MAO-A和MAO-B的活性,进行体内抑制活性实验以评估化合物3a,3d,3f,3i和3m的抑制活性。。体内抑制活性评估结果表明,化合物3a,3d,3f